Fredrik Piehl
Karolinska Institutet
H-index: 81
Europe-Sweden
Top articles of Fredrik Piehl
Lower complement C1q levels in first-episode psychosis and in schizophrenia
Brain, Behavior, and Immunity
2024/3/1
Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
European Journal of Neurology
2024/2/6
Fredrik Piehl
H-Index: 48
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
Journal of Neurology, Neurosurgery & Psychiatry
2024/2/1
Fredrik Piehl
H-Index: 48
Anders Svenningsson
H-Index: 30
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy
Journal of Neurology, Neurosurgery & Psychiatry
2024/2/1
Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury
Clinical Chemistry and Laboratory Medicine (CCLM)
2024/1/26
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis
Cell Reports Medicine
2024/1/16
Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
2024/1/2
Genetic variation in HIF1A is associated with smoldering inflammation and disease progression in Multiple Sclerosis
medRxiv
2024
Impact of Genetic Susceptibility on Multiple Sclerosis Immune Methylome (S17. 006)
2024/4/14
Granulocyte Activation and Astrocyte Damage Markers in CSF Differentiate Acute NMOSD and MOGAD from MS (P9-14.004)
2024/4/14
Neurofilaments as biomarkers in neurological disorders—towards clinical application
2024/4/12
Emerging cerebrospinal fluid biomarkers of disease activity and progression in multiple sclerosis
JAMA neurology
2024/4/1
Epidemiology of myasthenia gravis in Denmark, Finland and Sweden: a population-based observational study
Journal of Neurology, Neurosurgery & Psychiatry
2024/3/27
Fredrik Piehl
H-Index: 48
Real‐World Healthcare Cost Savings and Reduced Relapse Rate with Off‐Label Rituximab versus Disease‐Modifying Treatments Approved for Relapsing–Remitting Multiple Sclerosis: A …
Annals of Neurology
2024/3/26
Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta‐analysis
2024/3/20
Fredrik Piehl
H-Index: 48
Treating Multiple Sclerosis Throughout the Life Cycle of Disease
2024/3/4
Fredrik Piehl
H-Index: 48
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis
Nature Communications
2023/10/30
A comparison of administration and discontinuation of Natalizuamb in Sweden over time for patients treated with either sucutaneous (SC) or intravenous (IV) administration …
2023
Clinical Effectiveness and Safety of Cladribine Tablets for Patients Treated at least 24 Months in the Swedish post-market surveillance study" Immunomodulation and Multiple …
2023
pharmacogenomics of clinical response to natalizumab: a multi-centric study
MULTIPLE SCLEROSIS JOURNAL
2023/10/1
